Graziani The Nef protein alters T cell receptor (TCR) signaling et al., 1996) . In transgenic mice, Nef expression in T cells in T cells and is critical for the pathogenesis of AIDS.
blocks the development of CD4 ϩ T cells (Brady et al. , We used a transient expression assay in a human CD4 ⍣ 1993; Skowronski et al., 1993) and the infrequent mature T cell line to analyze the interaction of Nef with the CD4 ϩ T cells found in the peripheral lymphoid tissues TCR machinery. We show that, in addition to downshow elevated expression of activation markers (Lindemregulating CD4 expression on the cell surface, Nef ann et al., 1994) . Moreover, transgenic thymocytes blocks a receptor-proximal event in CD3 signaling.
expressing Nef respond with elevated mitogenic and Analysis of a large number of mutant Nef proteins calcium responses to T cell receptor (TCR) stimulademonstrated that the effects of Nef on CD4 expression tion with an anti-CD3 monoclonal antibody (MAb) and on CD3 signaling are separable. The ability of Nef . In contrast, in human T cell to block CD3 signaling was selectively abolished by lines, constitutive Nef expression is associated with mutations in the central part of the Nef protein and reduced IL-2 gene expression in response to anti-CD3 in particular by those known to disrupt the SH3 MAb (Luria et al., 1991; Collette et al., 1995) . Interestbinding surface in the structured core of Nef. In ingly, in human Jurkat T cells, a CD8-Nef fusion protein contrast, the ability of Nef to down-regulate CD4 can suppress or promote the activation of T cells depending expression was selectively abolished by two clusters of on its intracellular localization (Baur et al., 1994) . The mutations, one in the N-terminal and one in the opposing consequences of Nef expression in T cell lines C-terminal region of Nef. These two regions correspond in vitro and in primary mouse CD4 ϩ T lymphocytes to the two flexible loops in Nef as predicted by solution in vivo may reflect differences in the nature of the Nef-NMR analysis. We show that this general functional TCR interaction between these cells. organization is conserved between the Nef proteins How Nef alters TCR/CD3 signaling is not known, but of the human and simian immunodeficiency viruses genetic and biochemical studies have begun to define (HIV-1 and SIV). Our data demonstrate that Nef has possibly relevant interactions between Nef and cellular at least two independent mechanisms to alter TCR proteins. One such interaction is between Nef and the function and thus may interfere with a range of T cell CD4 co-receptor (Garcia and Miller, 1991; Aiken et al., responses. Introduction tude (Janeway, 1992; Weiss and Littman, 1994) . Nef targets these two interactions of CD4 both by inducing Evidence indicates that the nef gene of simian and human the endocytosis and degradation of CD4 in lysosomes and immunodeficiency viruses (SIV and HIV-1) is critical for by disrupting the association of CD4 with Lck (Aiken AIDS pathogenesis. Experiments in SIV-infected rhesus et al., 1994; Anderson et al., 1994; Rhee and Marsh, monkeys show that there is a strong selective pressure on 1994; Salghetti et al., 1995) . The effect of Nef on CD4 the virus to maintain a functional nef open reading frame.
and on the CD4-Lck complex was observed with natural Animals infected with SIV viruses carrying large deletions SIV and HIV-1 Nef proteins and therefore reflects a in nef exhibit low viral loads and do not develop AIDS conserved function of the viral protein (Anderson et al., (Kestler et al., 1991) . Moreover, studies of long-term 1993; Benson et al., 1993; . survivors of HIV-1 infection also indicate that nef can be Two biochemical interactions of Nef have been an important determinant of clinical outcome. In several described that putatively link Nef to signal transduction long-term non-progressors, the efficient control of HIV-1 pathways. One is with the SH3 domains of the Hck and infection is associated with deletions in nef (Deacon et al., Lyn protein tyrosine kinases of the Src family and involves 1995; Kirchhoff et al., 1995) or with an unusually high the conserved PxxP motif in Nef (Saksela et al., 1995) . frequency of defective nef alleles and functionally defective Nef proteins (Mariani et al., 1996) .
The other interaction is with the p62 serine kinase of the p21-activated kinase (PAK) family (Sawai et al., 1994 (Sawai et al., , 1995 Nunn and Marsh, 1996) . The Nef-PAK association was implicated as important for the effect of Nef on signal transduction in T cells (Baur et al., 1994) . Both of these interactions have mapped to the highly conserved core of the Nef molecule. The crystal and NMR structures of the Nef core that interacts with SH3 domains were solved recently (Grzesiek et al., 1996; Lee et al., 1996) . Since TCR signals that follow from antigen recognition events are involved in the regulation of all of the major aspects of T lymphocyte function, the interaction of Nef with the TCR machinery is likely to be important for AIDS pathogenesis. Here we describe the molecular determinants of the effect of Nef on two aspects of the TCR machinery; CD4 surface expression and CD3 signaling.
two color analysis of CD4 and CD69 antigen expression. Cells were transfected with 20 μg plasmids expressing the NA7 HIV-1 (panels 2 Using a transient expression assay to characterize a large and 5) or the mac239 SIV (panels 3 and 6) nef alleles or a control panel of mutant HIV-1 and SIV Nef proteins, we found empty vector (panels 1 and 4) and cultured overnight in the absence that: (i) Nef blocks a receptor-proximal event in the CD3 (-) or presence (α-CD3, 25 ng/ml) of HIT-3A anti-CD3 MAb.
pathway; (ii) the effects of Nef on CD4 surface expression and on CD3 signaling are independent; (iii) distinct regions of the Nef molecule are important for the effect on CD4 in CD69 expression was observed in untransfected subpopulations (CD4 high ) from cultures electroporated with expression and on CD3 signaling; (iv) association with the p62 kinase does not correlate with the effects of Nef NA7 and mac239 Nef expression vectors (compare panel 2 with 5 and panel 3 with 6 respectively). In contrast, the on CD4 down-regulation or on CD3 signaling. Our studies define novel molecular interactions of the Nef molecule positively transfected Nef-expressing CD4 low cells from the same cultures did not respond with increased CD69 that are important for the effects of Nef on the TCR machinery and suggest a structure-function model for the expression. Thus, both HIV-1 and SIV Nef can block CD3-initiated signaling events that are required for the Nef protein.
induction of CD69 expression in Jurkat T cells.
Results

Nef blocks an early event in CD3 signaling
Experiments were performed to localize within known Experimental design: transient assay of the effect of Nef on the TCR machinery signal transduction pathways the Nef-mediated block to induction of CD69 expression by anti-CD3 MAb. StimulaThe effects of Nef on CD4 surface expression and on TCR-mediated signaling were studied using a transient tion of T cells through the TCR results in activation of intracellular signal transduction mechanisms, including expression assay in the JJK CD4 ϩ subline of Jurkat T cells. The JJK cells were transfected with HIV-1 Nef or activation of both protein kinase C (PKC) and calciumdependent responses. Since CD69 expression can be SIV Nef expression plasmids and then stimulated with the mitogenic anti-CD3 MAb HIT3A. Since stimulation triggered by treating cells with PKC agonists (PMA) and calcium ionophores (A23187), we assayed the effect of of T cells via TCR/CD3 results in rapid induction of very early activation antigen (CD69) expression on the cell Nef on CD69 induction by these two agents. As shown in Figure 2A , exposure of Jurkat T cells to PMA or surface (Yokoyama et al., 1988; Ho et al., 1994) , induction of CD69 surface expression provided a convenient indica-A23187 resulted in CD69 induction similar to that induced by anti-CD3 MAb (compare panel 1 with panels 2-4). In tor of CD3 signaling. Flow cytometric analysis of CD4 and CD69 expression permitted quantitation of the effect marked contrast to anti-CD3 MAb-stimulated cells, CD69 expression levels were comparable between the Nefof Nef on CD4 and CD3 signaling simultaneously on a cell by cell basis.
expressing CD4 low cells and the non-transfected CD4 high population, following PMA or A23187 stimulation (see As shown in Figure 1 , transient transfection of the previously characterized natural HIV-1 nef allele NA7 panels 7 and 8). Control experiments demonstrated that CD4 low cells selectively expressed a co-transfected CD20 resulted in an~20-to 50-fold decrease in CD4 expression on the surface of marker and therefore represented the positively transfected cell population (see panels 9-12). Though it is possible positively transfected Nef-expressing cells (CD4 low cells; compare panels 1 and 2). A similar decrease in CD4 that PMA-and ionophore-induced CD69 expression may involve parallel (CD3-independent) pathways, our observexpression was observed following transfection with the mac239 nef allele from a pathogenic SIV strain (Regier ations suggest that Nef may block events upstream of PKC activation and upstream of cellular mechanisms and Desrosiers, 1990) (compare panels 1 and 3). These observations are in agreement with the previously reported regulated by an increase in intracellular calcium. Since TCR signaling involves the activation of several ability of both alleles to down-regulate surface expression of CD4 (Benson et al., 1993; downstream effector molecules, including Lck, Rac, Raf and Ras (Weiss and Littman, 1994; Zenner et al., 1995 Zenner et al., ), 1993 .
Exposure of JJK cells to anti-CD3 MAb resulted in a we asked which of these four molecules can induce CD69 expression. As shown in Figure 2B , transient expression readily detectable 3-to 7-fold increase in CD69 surface expression (compare panels 1 and 4). A similar increase of activated forms of Rac, Raf and Ras in Jurkat T cells NA7, or with a control empty vector (Vector, panels 1-4) and 3 μg vector expressing the CD20 marker. Cells were then cultured overnight in medium containing anti-CD3 MAb (α-CD3, 25 ng/ml), phorbol myristate acetate (PMA, 5 ng/ml), calcium ionophore A23187 (A23187, 0.2 μg/ml) or in medium alone (-). CD4 and CD69 expression on all cells that survived electroporation [(total cells), panels [1] [2] [3] [4] [5] [6] [7] [8] or on CD20-positive cells [(CD20 ϩ cells), panels 9-12] is shown. (B) Activated Lck, Rac, Raf and Ras induce CD69 antigen expression. Jurkat T cells were cotransfected with 5 μg plasmid expressing activated forms of mouse Lck (panels 2 and 7), Rac (panels 3 and 8), Raf (panels 4 and 9), Ras (panels 5 and 10) or a control empty vector (panels 1 and 6) and 3 μg CD20 reporter plasmid. CD4 and CD69 expression on cells surviving electroporation is shown on the left (Total cells) and that on CD20-positive cells is shown on the right (CD20 ϩ cells).
all resulted in efficient induction of CD69 in positively functions of the Nef protein, we analyzed a panel of both novel and previously studied mutant HIV-1 and SIV Nef transfected cells (compare panels 3-5 with 1 and 8-10 with 6). The activated form of Lck was also effective, proteins Saksela et al., 1995; Aiken et al., 1996; Mariani et al., 1996) . Thirty six although fewer cells showed a comparable increase in CD69 expression ( Figure 2B , see panels 2 and 7). The mutations located in the highly conserved central region and in the less conserved N-terminal and C-terminal indiscriminate induction of CD69 antigen expression by a wide variety of biochemical effectors and pharmacological regions of Nef were studied (see Figure 3 for the definition of the mutagenized regions of Nef). These experiments agents suggests that the CD69 gene is a target for several different pathways that branch downstream of TCR. Thus, defined four functional classes of mutations in Nef, the primary data for representatives of which are shown in efficient blocking by Nef of such a promiscuously responsive gene as CD69 indicates that Nef disrupts an early Figure 4 (complete data for all mutants are shown in Figures 5-7 ). The first class of mutations, represented by event in CD3 signaling, possibly by interfering with the recruitment of signaling molecules to the receptor. a lysine substitution for E174, disrupted the ability of NA7 Nef to down-regulate CD4 expression, but did not have a detectable effect on the ability of Nef to block The effects of Nef on CD4 surface expression and on CD3 signaling are independent CD3 signaling ( Figure 4 , compare panel 3 with 1 and 2 and panel 8 with 6 and 7). The second class, typified by To assess which amino acid residues in Nef contribute to its effects on CD4 expression and on CD3 signaling alanine substitutions for both the P72 and the P75 residues, preferentially disrupted the ability of Nef to block CD3 and to determine whether these effects reflect separate Grzesiek et al., 1996; Lee et al., 1996) . N-terminal myristoylation is also shown ( ). Conserved structural elements of the SIV mac239 Nef protein that show at least 65% amino acid identity with signaling, having only a minor effect on CD4 downmyristoylation signal and is known to diminish the activity of the viral protein in several cellular and viral assays regulation (Figure 4 , compare panel 4 with 1 and 2 and panel 9 with 6 and 7). Both of these observations indicate Aiken and Trono, 1995) . Mutations in 7.M2-7.M8 Nef were that the effects on CD4 and CD69 expression are separate functions of Nef. Mutations of the third class, exemplified designed to disrupt the structure of the N-terminal region by substituting alanine for charged residues or aspartate by alanine substitutions for R105 and R106, severely compromised both the effect of Nef on CD4 expression for glycines or alanines. The effect of mutant Nef proteins on CD4 expression was quantitated in dose-response and on CD3 signaling (Figure 4 , compare panel 5 with 1 and 2 and panel 10 with 6 and 7). Mutations of the final experiments, which allowed a reliable comparison of wildtype and mutant Nef proteins. As shown in Figure 5A , class did not alter the effect of Nef on CD4 and CD69 expression.
the mutations in 7.M1, 7.M5, 7.M6 and 7.M8 severely impaired the ability of Nef to down-regulate CD4 expression ( Figure 5A , panel 1). Analysis of the dose-response Mutations in the N-terminal region of HIV-1 Nef selectively disrupt CD4 down-regulation curves showed that for the wild-type NA7 plasmid, the half-maximal down-regulation of CD4 expression required Mutations which selectively disrupt the effect of Nef on CD4 expression were located in two regions of the Nef 0.15 μg DNA. In contrast, with the 7.M8 plasmid the same effect required~20 times more DNA (defined as molecule. These regions were analyzed separately in Figures 5 and 6. As shown in Figure 5A , one such region 5% of wild-type activity; see Figure 5A ). The 7.M2 and 7.M7 mutants were the same as the wild-type in their was defined by analyzing mutants in the 57 residue N-terminal segment of HIV-1 NA7 Nef (mutants 7.M1-ability to down-regulate CD4 expression. The ability of the mutant Nef proteins to block CD69 7.M8; see also Figure 3 for the definition of the N-terminal region). The mutation in 7.M1 Nef disrupts the N-terminal induction by anti-CD3 MAb was assessed by dose- response analysis, which allowed a reliable quantitation with 20 μg vector expressing the wild-type or mutant Nef protein and exposed to increasing doses of anti-CD3 MAb of this effect of Nef. In these experiments, the induction of CD69 surface expression was measured in cells transfected ( Figure 5A , panel 2). The wild-type NA7 Nef protein (NA7, panels 1 and 2) and mac239 (mac239, panels 3 and 4) Nef proteins on CD4 (panels 1 and 3) and CD69 (panels 2 and 4) expression was performed as described in Figure 5 .
blocked induction of CD69 expression for all three concenAs shown in Figure 5B , three mutations designed to disrupt the organization of the N-terminal region in mac239 trations of anti-CD3 MAb tested ( Figure 5A , compare NA7 and Vector in panel 1). In contrast, the myristoylationNef, by substituting alanine, proline and methionine residues with charged amino acids, severely reduced CD4 defective 7.M1 Nef did not block CD69 expression, even at the lowest dose of anti-CD3 MAb. Therefore, an intact down-regulation by Nef yet did not have a detectable effect on the ability of Nef to block CD69 induction myristoylation signal is required for Nef to block CD3 signaling. The remaining mutant Nef proteins blocked ( Figure 5B , see 239.M2, 239.M3 and 239.M4). Mutations in 239.M1 and 239.M5 did not have detectable effects on CD69 expression as well as the wild-type protein (the slight variation in CD69 expression level observed with the activities of Nef. Thus, despite dissimilar amino acid sequences, the N-terminal regions of NA7 and mac239 these proteins following stimulation of cells with 100 ng/ml anti-CD3 MAb was within the limits of reproNef proteins are functionally homologous. ducibility of the assay). Thus, the amino acid residues mutated in the 7.M5, 7.M6 and 7.M8 Nef proteins define
Mutations in the C-terminal region of HIV-1 and SIV Nef also selectively disrupt CD4 the N-terminal region of HIV-1 Nef that is required for the ability of Nef to down-regulate CD4 expression.
down-regulation
The second group of mutations that selectively disrupted CD4 down-regulation are located in the C-terminal part Mutations in the N-terminal region of SIV Nef also selectively disrupt CD4 down-regulation of the core of the NA7 molecule (see Figures 3 and 6) . A double alanine substitution at positions 174 and 175 in The amino acid sequence of the N-terminal region of HIV-1 Nef important for CD4 down-regulation is poorly 7.M19 reduced by Ͼ50-fold the ability of Nef to downregulate CD4 expression (Figure 6 , 7.M19; in agreement conserved between HIV-1 and SIV proteins (see Figure  3 ; Myers et al., 1993) . However, the HIV-1 and SIV with Aiken et al., 1996) . As can be seen from the doseresponse curves obtained with mutants 7.M20 and 7.M22, proteins can both down-regulate CD4 expression. To address whether the N-terminal regions of HIV-1 and SIV each of the two individual alanine substitutions contributed to the defect ( Figure 6B, panel 1) . In addition, a lysine Nef are functionally homologous we tested the effect of mutations in the N-terminal portions of the mac239 Nef substitution at position 174 (7.M21) completely disrupted CD4 down-regulation. A triple alanine substitution for molecule on CD4 down-regulation and on blocking of CD69 induction by anti-CD3 MAb.
three adjacent charged amino acids had a comparably 4 ) and on CD69 expression (panels 2 and 5) was performed as described in Figure 5 . The relative stability of the wild-type and mutant Nef proteins was determined as described in Materials and methods (panels 3 and 6). (C) Dose-response analysis (panels 1 and 2) and relative stabilities (panel 3) of mutant mac239 Nef proteins are shown.
detrimental effect on CD4 down-regulation (7.M23). As mac239 Nef is shown in Figure 6A . Initially, double and triple alanine substitutions (mutants 239.M10 and shown in Figure 6B , none of these mutations affected the ability of Nef to block CD69 induction (see 7.M19-7.M23 239.M13), similar to those mutations that disrupted CD4 down-regulation in NA7 Nef (mutants 7.M19 and 7.M23), in panel 2). These results defined a second region of Nef that is required for CD4 down-regulation but not for were tested ( Figure 6A ). As shown in Figure 6B , both mutations not only severely impaired the ability of mac239 blocking CD69 induction.
We tested whether the corresponding region of SIV Nef Nef to down-regulate CD4 expression, but also disrupted its effect on the induction of CD69 expression (see panels was similarly involved in CD4 down-regulation. The design of mutations made in the C-terminal region of 3 and 4 respectively), and both destabilized the Nef protein (data not shown). However, substitutions of charged amino acids at the same positions in mutants 239.M11 and 239.M12 resulted in proteins that were selectively defective for down-regulation of CD4 surface expression ( Figure  6B , see 239.M11, 239.M12 in panels 3 and 4). Therefore, the corresponding C-terminal regions of HIV-1 and SIV Nef are both required for CD4 down-regulation.
Mutations in the HIV-1 Nef core preferentially disrupt the effect on CD3 signaling
The conserved Nef core has been shown to associate with SH3 domains of Src family protein tyrosine kinases and with a PAK family serine kinase (Sawai et al., 1994; Saksela et al., 1995; Nunn and Marsh, 1996) . To assess the role of the Nef core in the down-regulation of CD4 expression and in the blocking of CD3 signaling, we assayed the effects of mutations that disrupted the conserved sequence elements in the central region of Nef ; see Figure 7A ). Notably, three of the mutant alleles, 7.M9, 7.M10 and 7.M13, resulted in Nef proteins that were unable to block induction of CD69 expression even by the lowest amount of anti-CD3 MAb tested ( Figure 7B , see 7.M9, 7.M10 in panel 2 and 7.M13 in panel 5). The mutation in 7.M9 Nef disrupted a stretch of negatively charged amino acid residues adjacent to the Nef core. Each of the remaining two mutations disrupted separate aspects of the SH3 binding surface in the Nef core: P72 and P75 of the PPII required for the association of Nef with the p62 serine kinase activity (Sawai et al., 1994) , resulted in an unstable protein that was severely impaired for down-regulation of motif in 239.M7 had only a partially disruptive effect on the ability of Nef to block CD69 induction by anti-CD3 both CD4 and CD69 expression (see 7.M16). The alanine substitution for T80 in 7.M14 Nef had a similar, but less MAb (see 239.M7 in Figure 7A and C). This result is in contrast to our observations with the PxxP motif mutation pronounced, phenotype. The remaining mutations did not result in overt phenotypes (Figure 7B, see 7.M11, 7.M12 in NA7 Nef (see 7.M10 in Figure 7) . Thus, the NA7 and mac239 Nef cores are organized differently and some and 7.M15). Thus, the central portion of the HIV-1 Nef molecule, which includes residues involved in SH3 residues in addition to P104 and P107 are responsible for the effect of mac239 Nef on CD3 signaling. interactions, is critical for the ability of Nef to block CD3 signaling. Moreover, these results demonstrate again that the effects of Nef on CD4 surface expression and CD3
The effect of Nef on CD69 surface expression does not correlate with the association of Nef with the signaling are separate.
To assess whether our observations from HIV-1 Nef p62 serine kinase activity Nef associates with a p62 serine kinase activity and this also apply to SIV Nef, the effects of selected mutations in the mac239 Nef core on CD4 and CD69 expression interaction may be important for its effect on signal transduction in T cells (Baur et al., 1994) . To assess were studied ( Figure 7A ). Three mutations that disrupted the acidic region (239.M6), substituted alanine residues whether this association is important for the effect of Nef on CD3 signaling and CD4 surface expression, we tested for T110 and S112 (239.M8) or substituted alanine residues for R127 and R128 (239.M9), which are required for the ability of selected mutant mac239 Nef proteins to associate with the p62 kinase activity in a co-immunoassociation of mac239 Nef with the p62 serine kinase activity, were tested (Sawai et al., 1995) . These mutations precipitation assay. As shown in Figure 8 , neither the mutations in 239.M2 and 239.M12, which disrupted the resulted in unstable proteins that were defective in both assays (see Figure 7C) . ability of Nef to down-regulate CD4 expression, nor those in 239.M6 and 239.M8, which compromised the ability Interestingly, mutating P104 and P107 of the PxxP of Nef to block CD69 induction, had a detectable effect differential contribution of CD4-dependent and CD4-independent effects may explain the different conon the association of Nef with the p62 phosphoprotein nor with other phosphoproteins found associated with sequences of Nef expression on CD3 signaling in CD4 ϩ Jurkat T cells and in CD4 ϩ T lymphocytes from transwild-type mac239 Nef (Figure 8 , compare lanes 7, 8, 10 and 12 with 2). Interestingly, the PxxP motif mutation genic mice. Our studies provide evidence for the molecular inter-(239.M7), which reduced the association of Nef with the p62 phosphoprotein by Ͼ500-fold (Figure 8, compare actions that underlie the effect of Nef on CD3 signaling and on CD4 down-regulation. The interaction(s) that is lane 9 with standards in 1-5), had only a small effect on the ability of Nef to modulate CD4 or CD69 expression required for the ability of Nef to block CD3 signaling was selectively compromised by mutations in the con-( Figure 7A and C, 239.M7 ). The lack of correlation between the effect of Nef on CD4 and CD69 expression served core of the HIV-1 Nef protein. The most drastic effect was with the 7.M10 Nef mutant, which contains and Nef-p62 association indicates that some other molecular interaction(s) is limiting for the effects of Nef on CD4 alanine substitutions for P72 and P75 in the PxxP motif, and with the 7.M13 Nef mutant, which contains an alanine expression and CD3 signaling.
substitution for D86 (see Figure 7A ). Recent results from NMR and crystal structure analyses of Nef-SH3 domain Discussion complexes indicated that these three amino acid residues form part of the SH3 binding surface of Nef and are We used a transient expression assay to study the interactions of the HIV-1 and SIV Nef proteins with the TCR important for high affinity specific interaction with Src family SH3 domains (Grzesiek et al., 1996; Lee et al. , machinery in a human CD4 ϩ Jurkat T cell line. We have demonstrated that natural HIV-1 and SIV Nef proteins 1996). The P72 and P75 residues are the critical components of the PPII helix of Nef that make contacts with block a subset of signals emanating from the TCR, as measured by a block to the induction of CD69 expression the SH3 domain core. The D86 residue contacts the RT loop of the SH3 domain. This latter interaction determines by anti-CD3 MAb. This observation is in agreement with previous data indicating that stable expression of the the specificity of Nef for a subset of Src family SH3 domains and stabilizes the overall interaction (Grzesiek HIV-1 Nef protein in Jurkat T cells can interfere with induction of IL-2 gene expression by lectins and by antiet al., 1996; Lee et al., 1996) . Thus, our observations establish a clear link between the SH3 binding surface of CD3 MAb (Luria et al., 1991; Baur et al., 1994; Collette et al., 1995) . However, since the Nef-mediated block to HIV-1 Nef and its ability to block CD3 signaling. Mutating the PxxP motif in the PPII helix in mac239 CD69 induction was bypassed by a calcium ionophore while the previously described Nef-induced block to the Nef had a much less drastic effect on CD3 blocking than the corresponding mutation in NA7 Nef (compare 7.M10 induction of IL-2 expression was not overcome by a calcium ionophore, it appears that the transient assay in Figure 7B with 239.M7 in Figure 7C ). However, it is evident from the structural studies that, in addition to the permitted us to measure new aspects of Nef function. This assay also allowed us to circumvent the possible selection PPII helix, other elements in the tertiary structure of the folded Nef molecule are required for high affinity for variants in signal transduction pathways in constitutively expressing Nef cell lines (Luria et al., 1991; Baur interaction with SH3 domains (Lee et al., 1996) . Therefore, it is possible that these additional stabilizing interactions et al., 1994).
Previous work has described Nef-induced down-regulaare sufficient to support a functional, although weakened, interaction between 239.M7 and a target SH3 domain. tion of CD4 and concomitant disruption of the CD4-Lck complex Anderson et al., 1994;  However, it is also possible that another non-SH3 interaction is important for the effect of mac239 Nef on CD3 Salghetti et al., 1995) . Results from our mutational analysis of the HIV-1 and SIV Nef proteins indicate that the effects signaling. Three cellular proteins, a p62 PAK family serine kinase of Nef on CD4 expression and on CD3 signaling are separate functions of the viral protein.
and the Hck and Lyn Src family tyrosine kinases, have been shown to associate with the Nef core (Sawai et al., We predict that the net effect of Nef on antigen-specific TCR signaling will be combinatorial. It will be determined 1994; Saksela et al., 1995) . Several observations argue against the importance of these associations for the effect by the ability of Nef to disrupt CD3 signaling as well as by the ability of Nef to down-regulate CD4 expression of Nef on TCR signaling. First, although the p62 serine kinase activity associates efficiently with mac239 Nef and and will depend on the amount of Nef expressed. This is perhaps best illustrated by the contrasting effects of Nef with Nef proteins from certain HIV-1 isolates (Sawai et al., 1995; Luo and Garcia, 1996) , it is evident from our expression in Jurkat T cells, where Nef blocks CD3 signaling, and in thymocytes in transgenic mice, where genetic and biochemical experiments that this association does not correlate with the ability of Nef to disrupt TCR CD3-dependent responses are enhanced Lindemann et al., 1994) . The positive effect signaling. Second, Hck is found predominantly in cells from the monocyte/macrophage lineage and is not signiof Nef on T cell activation in transgenic mice appears to require the CD4 molecule and may reflect the release of ficantly expressed in T cells (Brickell, 1992) . Third, neither Hck nor Lyn were found to be important for signal Lck from a complex with CD4 (Haughn et al., 1992; M.Lock, D.R.Littman and J.Skowronski, unpublished transduction in T cells (Lowell et al., 1994; Nishizumi et al., 1995) . Thus, interactions between the core region results). The level of Nef expression in T cells from the transgenic mice was lower than that required for blocking of Nef and other cellular targets must exist which explain the effect of Nef on signaling in T cells. CD69 induction in transiently transfected Jurkat T cells (M.Lock and J. Skowronski, unpublished results) . The
The ability of Nef to down-regulate CD4 expression exponentially growing cultures were electroporated at 200 V and 960 μF was severely and selectively disrupted by mutations in with a total of 10-20 μg DNA containing varying amounts of appropriate two regions of the NA7 Nef molecule. These regions, expression vectors and 3 μg CMV CD20 expression plasmid for use as located between amino acid residues 36 and 56 in the a marker of transfected cells (Zhu et al., 1993) . correspond to two flexible loops, as determined from and 0.1% sodium azide (PBS-FA). Cells were reacted in the wells of a structural studies (Grzesiek et al., 1996; Lee et al., 1996) . contacts with the same cellular targets. Skowronski and Mariani, 1995) , the
The abilities of Nef to alter CD4 expression and to alter machinery by Nef to enhance viral replication and/or (ii) a pH 8.0, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 2 μg/ml aprotinin, coordinated effort to alter the normal pattern of T cell complexes were then bound to protein G-agarose beads for 40 min at 4°C. The beads were then washed three times with lysis buffer, twice with lysis buffer without glycerol and once with kinase reaction buffer
Materials and methods
containing 50 mM Tris-HCl, pH 7.4, 200 mM NaCl, 5 mM MgCl 2 , 0.5% Triton X-100 and 0.1 mM sodium vanadate (Sawai et al., 1994) .
Plasmid construction
For the immune complex kinase assay, the beads were suspended in The protein coding region of the natural HIV-1 NA7 nef (Mariani and 50 μl ice-cold kinase reaction buffer containing 30 μCi [γ-32 P]ATP and of SIV mac239 'open' nef (Regier and Desrosiers, (7000 Ci/mmol; ICN) and the reaction was carried out for 5 min at 1993; kindly provided by R.C.Desrosiers) were subcloned between the room temperature. The reaction was stopped by addition of 500 μl iceXbaI and BamHI sites of plasmid pBS(-) (Stratagene) and oligonucleocold kinase reaction buffer containing 5 mM EDTA and 2 mM sodium tide-directed site-specific mutagenesis was performed as previously vanadate and the beads were then washed twice with this solution. The described . The mutated nef sequences washed beads were suspended in SDS sample buffer and the protein were verified by DNA sequencing and subcloned between the XbaI and complexes were recovered following 10 min incubation at 80°C. To BamHI sites of a T cell-specific pCD3-β expression vector, as previously evaluate the kinase activity present in the Nef immune complexes, described . The pCG and pCGT vectors (Tanaka aliquots of immune complexes were resolved on 9% polyacrylamide and Herr, 1990; Wilson et al., 1995) , containing constitutively active gels and dried gels were exposed to X-ray film and/or subjected to forms of Ras, Rac or Raf under the control of the CMV promoter, were phosphorimager analysis (BAS-1000, FUJI). provided by Linda van Aelst. Murine Lck cDNA, provided by Dan R.Littman, was subcloned into the pCD3-β and pCG expression vectors Immunoblot analysis of Nef expression using standard techniques (Sambrook et al., 1989) .
Cytoplasmic extracts from transiently transfected Cos-7 cells were prepared as described above. Aliquots of immune complexes prepared from Cos-7 cells were denatured in reducing sample buffer, resolved DNA transfections and stimulation of Jurkat T cells Jurkat T cells (JJK) expressing human CD4 at a high level, provided by on 14% polyacrylamide gels and electroblotted onto poly(vinylidene difluoride) membrane (Immobilon; Millipore) as described previously Dan R.Littman, were maintained in RPMI 1640 medium supplemented with 2 mM glutamine and 20 mM HEPES, pH 7.4, and cultures (Salghetti et al., 1995) . Membranes were incubated for 1 h in blocking solution containing NT buffer [150 mM NaCl, 50 mM Tris-HCl, pH 7.5, were diluted 1:10-1:20 every 3-4 days. Aliquots of 10 7 cells from
